 |
|
|
| |
Study of ABT-267 2-Day Monotherapy Followed By 12-Week Combination Therapy In Treatment-Naïve Patients With Chronic HCV Genotype 1 Infection
|
| |
| |
Reported by jules Levin
EASL 2013 April 25-28 Amsterdam
Michael Epstein1, Franco Felizarta2, Thomas Marbury3, Prajakta Badri4, Victoria Mullally4, Tami Pilot-Mati as4, Carolyn M Setze4, Andrew L Campbell4, Barry Bernstein4
1Investi gati ve Clinical Research, Annapolis, Maryland, United States; 2Private Practi ce, Bakersfi eld, California, United States; 3Orlando Clinical Research Center, Orlando, Florida, United States; 4AbbVie Inc., North Chicago, Illinois, United States
|
| |
|
|
|
|
|
